Latest Breaking News On - Alexandera soukas - Page 1 : comparemela.com

Diabetes drug promotes longevity by stimulating the body s production of ether lipids

Metformin, the most commonly used drug to treat type 2 diabetes, not only lowers blood sugar levels but has revealed to extend lifespan in C. Elegans an animal model that shares similar metabolic systems with humans and are often used to model human diseases.

United statesG lucydalila cedilloAdebanjo adedojaKhoi daoYifei zhouAlexandera soukasZhaozhi liSainan liSeanp curranSudeshna dasLukem murphyYuyao zhangNicholasd petersonMegan craigMohit jainArmen yerevanian

How diabetes drug metformin extends lifespan in lab models

How diabetes drug metformin extends lifespan in lab models
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

United statesKhoi daoG lucydalila cedilloZhaozhi liFasihm ahsanNicolel stuhrSinclair emansAdebanjo adedojaLukem murphySeanp curranYuyao zhangSudeshna dasArmen yerevanianMohit jainAlexandera soukasSainan li

Diabetes Drug Prolongs Lifespan in Lab Models, Study Shows

Diabetes Drug Prolongs Lifespan in Lab Models, Study Shows
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandera soukasLukem murphyYifei zhouSinclair emansAdebanjo adedojaMohit jainSudeshna dasSeanp curranArmen yerevanianSainan liYuyao zhangFasihm ahsanNicolel stuhrNicholasd petersonKhoi dao

Study reveals how diabetes drug extends lifespan in lab models

Study reveals how diabetes drug extends lifespan in lab models
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandera soukasLucydalila cedilloProfessor at harvard medical schoolResearch scholarMassachusetts general hospitalAssociate directorGenomic medicineAssociate professorHarvard medical schoolWeissman family

Potential Approach for Overcoming Insulin Resistance in Type 2 Diabetes

An enzyme called SGK has been found to drive insulin resistance in the liver and may be a potential therapeutic target for type 2 diabetes (T2D).

United statesAlexandera soukasHarvard medical schoolMassachusetts general hospitalCell reportsGenomic medicineDiabetes unitHarvard medicalBlocking sgk